October 19, 2011— W. L. Gore and Associates announced that the company purchased the assets and intellectual property of now defunct company NMT Medical Inc. The purchase included the data related to CLOSURE I, a prospective, multi-center, randomized controlled trial of patent foramen ovale (PFO) closure with the Starflex Device versus best medical therapy for the prevention of recurrent stroke and /or transient ischemic attack (TIA) in patients with cryptogenic stroke/TIA and PFO.
“We made the decision to acquire these assets in the spirit of collaboration and in the interest of advancing scientific and medical understanding,” said Stuart Broyles, Ph.D., associate with the Gore Medical division stroke business. The study data were acquired with the rest of the NMT assets, but the transaction did not transfer any liabilities or regulatory obligations of NMT.
The acquisition came after NMT ceased operations earlier this year.
Gore Medical products include technology for transcatheter repair of congenital heart defect holes in the heart, including PFO closure.
For more information: www.goremedical.com